Locations:

Cancer

September 30, 2022/Cancer/Research

New Selective ER Modulator Shows Promising Clinical Activity in HR-positive Metastatic Breast Cancer with ESR1 Mutation After Progression

Impressive progression-free survival observed in phase 2 study

Microscopic image showing adenocarcinoma of Prostate.

September 20, 2022/Cancer

In Search of Improved Risk Modeling for Cribriform, Intraductal Carcinoma of the Prostate

Can genomic classifiers contemporize stratification?

September 13, 2022/Cancer

Non-Small Cell Lung Cancer Trial Underway for Novel Immunotherapy Treatment

September 13, 2022/Cancer

Florida Researcher Targets High-Risk Oral Squamous Cell Carcinoma

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

September 13, 2022/Cancer

Tattooless Radiation Therapy Benefits More Than Skin Deep

September 13, 2022/Cancer/Blood Cancers

Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Retrospective study yields clues to understanding risk of secondary myeloid neoplasms

August 31, 2022/Cancer/Research

Investigational PET Imaging Agent Being Explored as a Predictive Biomarker For Response to Standard Chemotherapies

Pilot Study at Cleveland Clinic is Testing Feasibility and Biodistribution

August 22, 2022/Cancer/Research

Distinct PHTS-related Breast Cancer Genomic Characteristics Discovered

Findings support need for personalized disease management

22-CNR-3103108-CQD-Hero-650×450-LRI flip

August 9, 2022/Cancer/Research

Tumors with Specific Genetic Mutations Show Response to Immune Checkpoint Blockade Therapy

Pathogenic POLE/POLD1 mutations lead to improved response to immune checkpoint blockade therapy

August 8, 2022/Cancer

Radium Knocks Out Tumor Cells in Case of Unresectable Paraspinal Osteosarcoma

The decision to use 223-radium, and an outcome that exceeded expectations

BackPage 32 of 85Next